|
[1]
|
陆明康, 侯希相, 殷美莉, 等. 氯氮平主要副反应的临床分析(附60例报告) [J].中华神经精神科杂志, 1991, 24(2): 71-74.
|
|
[2]
|
Claghorn, J., Honigfeld, G., Abuzzahab, F.S., et al. (1987) The Risks and Benefits of Clozapine Versus Chlorpromazine. Journal of Clinical Psychopharmacology, 7, 377-384. [Google Scholar] [CrossRef]
|
|
[3]
|
沈渔邨. 精神病学[M]. 第5版. 北京: 人民卫生出版社, 2009: 849.
|
|
[4]
|
Subas, E., Alkan, S., Yalcin, S., et al. (2018) Rapid-Onset Agranulocytosis Following the Intro-duction of Clozapine: A Case Report. Klinik Psikofarmakoloji Bulteni, 28, 255.
|
|
[5]
|
Honigfeld, G., Arellano, F., Sethi, J., et al. (1998) Reducing Clozapine-Related Morbidity and Mortality: 5 Years of Experience with the Clozaril National Registry. The Journal of Clinical Psychiatry, 59, 3-7.
|
|
[6]
|
侯成业, 梁英. 三种非典型抗精神病药物治疗精神分裂症对白细胞影响的对照研究[J]. 中国冶金工业医学杂志, 2017, 34(5): 499-501.
|
|
[7]
|
卢翠翠, 赵文博, 沈姗, 张文, 沈承武. 药物诱导的粒细胞缺乏症研究进展[J]. 中国现代应用药学, 2021, 38(12): 1524-1528. [Google Scholar] [CrossRef]
|
|
[8]
|
Cowan, C. and Oakley, C. (2007) Leukopenia and Neutropenia Induced by Quetiapine. Progress in Neuro-Psycho- pharmacology and Biological Psychiatry, 31, 292-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
白茹. 氯氮平引起粒细胞减少或缺乏的预测[J]. 临床精神医学杂志, 2005, 15(6): 365.
|
|
[10]
|
蒲玉春, 阮淑芳. 抗精神分裂药致白细胞减少的调查分析[J]. 深圳中西医结合杂志, 2016, 26(12): 67-69.
|
|
[11]
|
杨健身, 张尉良. 氯氮平与粒细胞缺乏[J]. 上海精神医学杂志, 1990, 新2(4): 189-190.
|